论文部分内容阅读
目的:探讨高危型人乳头瘤病毒(HPV)感染应用金波栓(抗HPV生物蛋白敷料)治疗的临床疗效。方法:随机将144例高危型HPV感染者分为A组及B组两组,每组72例。A组接受金波治疗,B组接受保妇康栓治疗。对比两组临床效果。结果:A组治疗后3个月、6个月及9个月后转阴率分别为66.67%、72.22%、75%,明显高于B组的15.28%、27.78%及27.78%(P<0.05)。结论:高危型HPV感染应用金波栓治疗可显著提高转阴率。
Objective: To investigate the clinical effect of high-risk human papillomavirus (HPV) infection treated with Jinbubi (anti-HPV biological protein dressing). Methods: A total of 144 cases of high risk HPV infection were randomly divided into two groups A and B, with 72 cases in each group. A group received Jinbo treatment, B group received Baofukang suppository treatment. Compare the clinical effect of two groups. Results: The rates of negative conversion in group A at 3 months, 6 months and 9 months after treatment were 66.67%, 72.22% and 75%, respectively, which were significantly higher than those in group B (15.28%, 27.78% and 27.78%, P <0.05 ). Conclusion: Treating HPV infection with high-risk HPV infection can significantly increase the rate of negative conversion.